UB-VV410

· Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UB-VV410, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis [Phase 1]